Concepedia

John Forster

JF

6

Publications

4.1K

Citations

6

H-Index

1994

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

Duke Medical Center

Groote Schuur Hospital

Dana-Farber Cancer Institute

John Forster is an author at GlaxoSmithKline (United States) specializing in cancer therapeutics, breast cancer, and oncology.

Top concepts

Publications per year

1994–2009

6

Publications

6

Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer

Charles E. Geyer, John Forster, Deborah Lindquist et al. · New England Journal of Medicine · 2006 · 3.4K citations · Full text

A phase II study of lapatinib monotherapy in chemotherapy-refractory HER2-positive and HER2-negative advanced or metastatic breast cancer

Harold J. Burstein, Anna Maria Storniolo, Sandra Franco et al. · Annals of Oncology · 2008 · 205 citations

, , +7

Single-agent lapatinib for HER2-overexpressing advanced or metastatic breast cancer that progressed on first- or second-line trastuzumab-containing regimens

Kimberly Blackwell, Mark D. Pegram, Elizabeth Tan-Chiu et al. · Annals of Oncology · 2009 · 167 citations · Full text

, , +8

Ondansetron Compared with Granisetron in the Prophylaxis of Cisplatin-lnduced Acute Emesis: A Multicentre Double-Blind, Randomised, Parallel-Group Study

Paul Ruff, W. Paska, L. Goedhals et al. · Oncology · 1994 · 122 citations

Adjuvant Therapy With the Monoclonal Antibody Edrecolomab Plus Fluorouracil-Based Therapy Does Not Improve Overall Survival of Patients With Stage III Colon Cancer

Anthony Fields, Alan Keller, Lee S. Schwartzberg et al. · Journal of Clinical Oncology · 2009 · 82 citations · Full text

Rows per page

1–5 of 6